An in-depth insight into many miRNA functions and their interplay with the P13K/AKT/mTOR pathway has revealed both oncogenic and tumor suppressor miRNAs, thus advancing the identification of surrogate biomarkers of drug sensitivity [13] and potential miRNA-targeting agents. This evidence concerns the gene MTOR and neoplasm.